Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA9 | Q16790 | 9/20 | 0.78 |
| ▸ | CA12 | O43570 | 8/20 | 0.78 |
| ▸ | CA1 | P00915 | 8/20 | 0.78 |
| ▸ | CA7 | P43166 | 8/20 | 0.78 |
| ▸ | CA13 | Q8N1Q1 | 8/20 | 0.78 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.77 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.77 |
| ▸ | MCL1 | Q07820 | 5/20 | 0.77 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.77 |
| ▸ | HPGD | P15428 | 4/20 | 0.77 |
| ▸ | MEN1 | O00255 | 3/20 | 0.77 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.77 |
| ▸ | CASP1 | P29466 | 3/20 | 0.77 |
| ▸ | CASP7 | P55210 | 3/20 | 0.77 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.77 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.77 |
| ▸ | MAPT | P10636 | 2/20 | 0.77 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.77 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.77 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30098746 | 1.00 | CA9 (0.78) | CA9CA12CA1CA7CA13 | |
| SCHEMBL3190311 | 0.88 | CA9 (1.00) | CA9CA12CA1CA7CA13 | |
| SCHEMBL29396102 | 0.88 | CA9 (1.00) | CA9CA12CA1CA7CA13 | |
| Fraxetin SCHEMBL43472 | 0.87 | CA9 (1.00) | CA9CA12CA1CA7CA13 | |
| Fraxetin SCHEMBL30010613 | 0.87 | CA9 (1.00) | CA9CA12CA1CA7CA13 | |
| Methoxymethane SCHEMBL2253445 | 0.86 | CA9 (0.97) | CA9CA12CA1CA7CA13 | |
| SCHEMBL30152142 | 0.86 | CA9 (0.66) | CA9CA12CA1CA7CA13 | |
| SCHEMBL14296936 | 0.86 | CA9 (0.79) | CA9CA12CA1CA7CA13 | |
| Fraxidin Methyl Ether SCHEMBL2464275 | 0.85 | CA9 (1.00) | CA9CA12CA1CA7CA13 | |
| SCHEMBL16015213 | 0.84 | CA9 (0.77) | CA9CA12CA1CA7CA13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115536932-A | Halogen-free flame-retardant insulating cable material and preparation method thereof | 国网河南省电力公司镇平县供电公司 | 2022-12-30 | — | — | CN | claimed |
| WO-2015081199-A1 | COMPOSITIONS AND METHODS FOR TREATING HERPESVIRUS INFECTION | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2015-06-04 | — | — | WO | claimed |
| US-20070134711-A1 | Compositions of eleutherosides capable of modulating protein expresion | BONAGURA VINCENT R | 2007-06-14 | — | — | US | claimed |
| US-20030175777-A1 | Eleutherosides as adjuncts for vaccines and immune modulation | BONAGURA VINCENT R (US) | 2003-09-18 | — | — | US | claimed |
| WO-2003074000-A2 | ELEUTHEROSIDES AS ADJUNCTS FOR VACCINES AND IMMUNE MODULATION | OMEGA PHARMACEUTICAL, INC. (US) | 2003-09-12 | — | — | WO | claimed |
| JP-60092204-A | — | — | None | — | — | JP | disclosed |
| EP-4635472-A1 | COSMETIC COMPOSITION COMPRISING AN EXTRACT OF FRAXINUS EXCELSIOR ASH BARK SOLUBILIZED IN JUGLANS REGIA WALNUT SEED OIL AND POLYGLYCERYL-4 OLEATE AND TOCOPHEROL | Société De Recherche Cosmétique S.à.r.L. (LU) | 2025-10-22 | — | — | EP | disclosed |
| CN-119757571-A | Universal inflammation recovery preparation characteristic spectrum and construction method and application thereof | 广西万通制药有限公司 | 2025-04-04 | — | — | CN | disclosed |
| CN-119752834-A | Oxygen methyl transferase and application thereof in biosynthesis of isofraxidin and fraxidin | 中国农业科学院深圳农业基因组研究所(岭南现代农业科学与技术广东省实验室深圳分中心) | 2025-04-04 | — | — | CN | disclosed |
| CN-118641662-B | Detection method for simultaneously measuring multiple components in turbidity-resolving, stagnation-resolving and arthralgia-removing formula | 福建中医药大学 | 2025-03-21 | — | — | CN | disclosed |
| CN-118641662-A | Detection method for simultaneously measuring multiple components in turbidity-resolving, stagnation-resolving and arthralgia-removing formula | 福建中医药大学 | 2024-09-13 | — | — | CN | disclosed |
| CN-118584013-A | Method for simultaneously determining contents of various components in turbidity-resolving, stagnation-resolving and arthralgia-removing formula based on UHPLC-QqQ-MS/MS technology | 福建中医药大学 | 2024-09-03 | — | — | CN | disclosed |
| US-20030175777-A1 | Eleutherosides as adjuncts for vaccines and immune modulation | BONAGURA VINCENT R (US) | 2003-09-18 | — | — | US | disclosed |
| US-20030175777-A1 | Eleutherosides as adjuncts for vaccines and immune modulation | BONAGURA VINCENT R (US) | 2003-09-18 | — | — | US | disclosed |
| WO-2003074000-A2 | ELEUTHEROSIDES AS ADJUNCTS FOR VACCINES AND IMMUNE MODULATION | OMEGA PHARMACEUTICAL, INC. (US) | 2003-09-12 | — | — | WO | disclosed |
| WO-2003074000-A2 | ELEUTHEROSIDES AS ADJUNCTS FOR VACCINES AND IMMUNE MODULATION | OMEGA PHARMACEUTICAL, INC. (US) | 2003-09-12 | — | — | WO | disclosed |
| US-20020002139-A1 | Methods for treating pathologies | OMEGA PHARMACEUTICAL, INC. | 2002-01-03 | — | — | US | disclosed |
| WO-1994026282-A1 | METHODS FOR TREATING PATHOLOGIES | OMEGA PHARMACEUTICALS, INC. (US) | 1994-11-24 | — | — | WO | disclosed |
| JP-S6092204-A | COSMETIC | LION CORP | 1985-05-23 | — | — | JP | disclosed |
| JP-S0692204-A | — | — | 0001-01-01 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020002139-A1 | Methods for treating pathologies | TNF, IL5, CCL11 | CA9 3859/4885CA12 2513/4885CA1 4004/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.